Price T Rowe Associates Inc Haemonetics Corp Transaction History

Price T Rowe Associates Inc

  • $867 Billion
  • Q4 2024

A detailed history of Price T Rowe Associates Inc transactions in Haemonetics Corp stock. As of the latest transaction made, Price T Rowe Associates Inc holds 354,281 shares of HAE stock, worth $22.3 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares
354,281
Previous 328,664 7.79%
Holding current value
$22.3 Million
Previous $26.4 Million 4.71%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 14, 2025
BUY
$71.16 - $93.38 $1.82 Million - $2.39 Million
25,617 Added 7.79%
354,281 $27.7 Million
Q3 2024

Nov 14, 2024
SELL
$72.45 - $91.58 $1.41 Million - $1.78 Million
-19,397 Reduced 5.57%
328,664 $26.4 Million
Q2 2024

Aug 14, 2024
SELL
$81.24 - $97.37 $17.4 Million - $20.9 Million
-214,393 Reduced 38.12%
348,061 $28.8 Million
Q1 2024

May 15, 2024
BUY
$71.24 - $85.35 $11.2 Million - $13.4 Million
156,665 Added 38.61%
562,454 $48 Million
Q4 2023

Feb 14, 2024
SELL
$80.59 - $92.61 $9.21 Million - $10.6 Million
-114,335 Reduced 21.98%
405,789 $34.7 Million
Q3 2023

Nov 14, 2023
SELL
$82.56 - $93.49 $112,694 - $127,613
-1,365 Reduced 0.26%
520,124 $46.6 Million
Q2 2023

Aug 14, 2023
BUY
$80.84 - $89.45 $2.89 Million - $3.2 Million
35,733 Added 7.36%
521,489 $44.4 Million
Q1 2023

May 15, 2023
BUY
$72.75 - $90.6 $18,260 - $22,740
251 Added 0.05%
485,756 $40.2 Million
Q4 2022

Feb 14, 2023
BUY
$73.85 - $86.14 $5.87 Million - $6.85 Million
79,532 Added 19.59%
485,505 $38.2 Million
Q3 2022

Nov 14, 2022
BUY
$63.3 - $78.66 $5.59 Million - $6.95 Million
88,354 Added 27.82%
405,973 $30.1 Million
Q2 2022

Aug 15, 2022
BUY
$49.27 - $66.08 $1.64 Million - $2.2 Million
33,266 Added 11.7%
317,619 $20.7 Million
Q1 2022

May 16, 2022
SELL
$43.77 - $63.22 $1.75 Million - $2.53 Million
-40,007 Reduced 12.33%
284,353 $18 Million
Q4 2021

Feb 14, 2022
SELL
$49.55 - $74.59 $1.33 Million - $2.01 Million
-26,905 Reduced 7.66%
324,360 $17.2 Million
Q3 2021

Nov 15, 2021
SELL
$57.6 - $70.59 $11.8 Million - $14.5 Million
-205,049 Reduced 36.86%
351,265 $24.8 Million
Q2 2021

Aug 16, 2021
BUY
$51.81 - $118.56 $219,778 - $502,931
4,242 Added 0.77%
556,314 $37.1 Million
Q1 2021

May 17, 2021
SELL
$111.01 - $139.48 $6.21 Million - $7.81 Million
-55,960 Reduced 9.2%
552,072 $61.3 Million
Q4 2020

Feb 16, 2021
BUY
$88.75 - $119.95 $54 Million - $72.9 Million
608,032 New
608,032 $72.2 Million

Others Institutions Holding HAE

# of Institutions
349
Shares Held
55.7M
Call Options Held
600K
Put Options Held
474K
View Full List

About HAEMONETICS CORP

HAE Quotes by TradingView
  • Ticker HAE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 51,316,500
  • Market Cap $3.23B
  • Description
  • Haemonetics Corporation, a healthcare company, provides medical products and solutions. It operates through three segments: Plasma, Blood Center, and Hospital. The company offers automated plasma collection devices, related disposables, and software, including NexSys PCS and PCS2 plasmapheresis equipment and related disposables and intravenous s...
More about HAE
Track This Portfolio

Track Price T Rowe Associates Inc Portfolio

Follow Price T Rowe Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Price T Rowe Associates Inc , based on Form 13F filings with the SEC.

News

Stay updated on Price T Rowe Associates Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email